Skip to content

Trinity Biotech 400-5-1000

by Trinity Biotech Public Limited Company

Trinity Biotech 400-5-1000 is a medical device (FDA Class II; FDA product code JBG, Glucose-6-Phosphate Dehydrogenase (Erythrocytic), Spot) made by Trinity Biotech Public Limited Company, listed in FDA GUDID since 6 Oct 2017 (UDI-DI 05391516741699), registry data as of 23 Oct 2026.

Listed FDA GUDID listing, no authorization on record

Valid until

Not applicable

Database listing, no authorization

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None

No authorization documents

Trust

Unverified

Source GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number05391516741699 UDI-DI Date6 Oct 2017ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
Mineral Oil
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — GUDID listing Listed

Specification

GUDID

Trade name
Trinity Biotech
Generic name
Red cell glucose-6-phosphate dehydrogenase (G6PD) IVD, reagent
Model / Ref / Catalog
400-5-1000
Primary DI / UDI-DI
05391516741699
FDA product code
JBG
GMDN term
Red cell glucose-6-phosphate dehydrogenase (G6PD) IVD, reagent
Device class
Class II
Regulation number
864.7360
GUDID distribution status
In Commercial Distribution
Size
Total Volume — 1000 Milliliter

Other devices from Trinity Biotech Public Limited Company

See all devices from Trinity Biotech Public Limited Company →

Properties

  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (12, all answered No)